2 news items
Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
ENLV
26 Feb 24
of patients' knees and making their joints feel wobbly.Treatment can include surgery, but most healthcare providers attempt non-surgical
Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals
ENLV
21 Feb 24
this complex healthcare challenge and unmet medical condition.A clinical-stage macrophage reprogramming immunotherapy company, Enlivex has completed
- Prev
- 1
- Next